BRWM
DNTH icon

B. Riley Wealth Management’s Dianthus Therapeutics DNTH Stock Holding History

B. Riley Wealth Management’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$13K Buy
+669
New +$16.5K ﹤0.01% 712

Other funds holding DNTH

TGI
TRV GP IV Boston, Massachusetts $254M AUM 426.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

B. Riley Wealth Management's DNTH Position: Q2 2022 in Review

B. Riley Wealth Management opened a new position in Dianthus Therapeutics (DNTH) in Q2 2022: 669 shares worth $13K. The stake represents ﹤0.01% of the portfolio and ranks #712 among its holdings.

75 funds tracked by Wall St. Rank hold DNTH as of Q2 2022.

  • B. Riley Wealth Management held 669 shares of Dianthus Therapeutics worth $13K as of Q2 2022.
  • Dianthus Therapeutics was a new B. Riley Wealth Management position in Q2 2022.
  • Dianthus Therapeutics made up ﹤0.01% of B. Riley Wealth Management's portfolio in Q2 2022, its #712 holding.
  • 75 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q2 2022.

Based on B. Riley Wealth Management's 13F filing for Q2 2022, filed 9 Sep 2022.